Dr. Rachel Bishop

speaker
160 appearances 1 recordings 1 series first heard Jul 2026 last heard 2 Jul

Dr. Rachel Bishop’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Jul OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment
Now, even with macular degeneration, we have excellent treatments for what we call wet macular degeneration and emerging treatments for dry macular degeneration.
But you have to, of course, identify it to be able to treat it.
Well, it has to do a little bit with whether abnormal blood vessels grow under the retina versus the retina cells just die.
So the physiology is a little complicated, but basically patients will say, oh, my doctor gives me eye injections.
to preserve my vision.
And that used to mean it was just wet macular degeneration.
The newer treatments that have emerged very recently now also slow the progression of this dry form, which is kind of like a slow retinal cell death.
So I'd say the research in macular degeneration has been very helpful for preserving vision.
Well, you know, and I don't even think of cataract as a disease because it's a natural aging change of the eye.
Everybody will get cataracts if they live long enough.
And really the time to do cataract surgery, which is an excellent surgery, is when it's bothering you.
A doctor won't say we have to do it, unlike these other treatments for glaucoma or macular degeneration where we really would push to be able to save the vision.
With cataracts, you would notice a slow decline in vision, glare from headlights at night, things like this.
And when it's becoming a quality of life issue, then your ophthalmologist would offer you cataract surgery.
So you had mentioned these dry and wet.
With wet macular degeneration, we used to not have anything we could do, and really a lot of people went blind, lost central vision from it.
The treatments with, it's called antivascular endothelial growth factor.
It's a long word, VEGF.
Those have preserved vision in millions of patients.
The dry macular degeneration is kind of pushing the envelope of where our research has gone, and I hope we continue to improve those treatments.
Showing 61–80 of 160 · page 4 of 8 ← Previous Next →